C Y Li

444 total citations
6 papers, 327 citations indexed

About

C Y Li is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, C Y Li has authored 6 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology, 2 papers in Genetics and 2 papers in Oncology. Recurrent topics in C Y Li's work include Cytokine Signaling Pathways and Interactions (1 paper), Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper) and T-cell and Retrovirus Studies (1 paper). C Y Li is often cited by papers focused on Cytokine Signaling Pathways and Interactions (1 paper), Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper) and T-cell and Retrovirus Studies (1 paper). C Y Li collaborates with scholars based in United States and China. C Y Li's co-authors include Ayalew Tefferi, Ruben A. Mesa, Curtis A. Hanson, Thomas E. Witzig, Terra L. Lasho, Christy M. Finke, Wei Wu, Jinsheng Huang, Animesh Pardanani and Thomas M. Habermann and has published in prestigious journals such as Journal of Clinical Oncology, Leukemia and ISPRS International Journal of Geo-Information.

In The Last Decade

C Y Li

5 papers receiving 325 citations

Peers

Countries citing papers authored by C Y Li

Since Specialization

Citations

This map shows the geographic impact of C Y Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Y Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Y Li more than expected).

Fields of papers citing papers by C Y Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Y Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Y Li. The network helps show where C Y Li may publish in the future.

Co-authorship network of co-authors of C Y Li

This figure shows the co-authorship network connecting the top 25 collaborators of C Y Li. A scholar is included among the top collaborators of C Y Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Y Li. C Y Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Characterization of HZ0412a, a novel potent humanized anti-IL-6 receptor antibody that blocks IL-6R binding to gp130 2023 ·PubMed ·Jianzhong Han, (unknown), Yue Xu, (unknown), Li Li, (unknown), C Y Li, Hongjun Liu, Yu Chen, Jian Huang	4
2	Explaining Theft Using Offenders’ Activity Space Inferred from Residents’ Mobile Phone Data 2023 ·ISPRS International Journal of Geo-Information ·Lin Liu, C Y Li, Luzi Xiao, Guangwen Song	1
3	[Correlation analysis of dynamic enhanced energy spectrum CT parameters with Ki-67 high expression in hepatocellular carcinoma]. 2023 ·PubMed ·C Y Li, Yi Lin, Xuanfeng Ding, (unknown), (unknown), Xin Yue	0
4	Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival 2008 ·Leukemia ·Ayalew Tefferi, Terra L. Lasho, Jinsheng Huang, Christy M. Finke, Ruben A. Mesa, C Y Li, Wei Wu, Curtis A. Hanson, Animesh Pardanani	178
5	Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. 1997 ·Journal of Clinical Oncology ·S. Ansell, Thomas M. Habermann, Paul J. Kurtin, Thomas E. Witzig, (unknown), C Y Li, David J. Inwards, Joseph P. Colgan	112
6	Phase I study of combined 2-chlorodeoxyadenosine and chlorambucil in chronic lymphoid leukemia and low-grade lymphoma. 1994 ·Journal of Clinical Oncology ·Ayalew Tefferi, Thomas E. Witzig, Joel M. Reid, C Y Li, Matthew M. Ames	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact